Private Capital Group, LLC Emergent Bio Solutions Inc. Transaction History

Private Capital Group, LLC

$133 Million
Q2 2022

A detailed history of Private Capital Group, LLC transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 171 shares of EBS stock, worth $1,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares

171

Previous 179 4.47%

Holding current value

$1,427

Previous $7,000 28.57%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$27.42 - $43.63 $219 - $349	-8 Reduced 4.47%	171 $5,000
Q1 2022 Apr 21, 2022	BUY	$36.48 - $52.22 $5,471 - $7,833	150 Added 517.24%	179 $7,000
Q4 2021 Jan 24, 2022	SELL	$33.11 - $55.01 $7,615 - $12,652	-230 Reduced 88.8%	29 $1,000
Q3 2021 Oct 13, 2021	SELL	$50.07 - $66.05 $17,023 - $22,457	-340 Reduced 56.76%	259 $13,000
Q2 2021 Jul 26, 2021	SELL	$56.61 - $80.46 $63,516 - $90,276	-1,122 Reduced 65.19%	599 $38,000
Q1 2021 Apr 12, 2021	SELL	$86.23 - $125.19 $16,297 - $23,660	-189 Reduced 9.9%	1,721 $160,000
Q4 2020 Jan 26, 2021	BUY	$79.17 - $111.47 $15,438 - $21,736	195 Added 11.37%	1,910 $171,000
Q3 2020 Nov 12, 2020	SELL	$81.91 - $134.94 $28,668 - $47,229	-350 Reduced 16.95%	1,715 $177,000
Q2 2020 Aug 13, 2020	SELL	$54.33 - $89.52 $15,810 - $26,050	-291 Reduced 12.35%	2,065 $163,000
Q1 2020 May 07, 2020	SELL	$49.34 - $68.76 $4,637 - $6,463	-94 Reduced 3.84%	2,356 $136,000
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $15,158 - $17,481	296 Added 13.74%	2,450 $132,000
Q3 2019 Nov 13, 2019	SELL	$40.6 - $57.2 $9,865 - $13,899	-243 Reduced 10.14%	2,154 $113,000
Q2 2019 Aug 15, 2019	BUY	$39.92 - $53.86 $9,540 - $12,872	239 Added 11.08%	2,397 $121,000
Q1 2019 Apr 26, 2019	SELL	$48.23 - $66.16 $4,871 - $6,682	-101 Reduced 4.47%	2,158 $109,000
Q4 2018 Jan 28, 2019	BUY	$55.63 - $73.24 $2,280 - $3,002	41 Added 1.85%	2,259 $134,000
Q3 2018 Oct 31, 2018	SELL	$52.05 - $66.51 $9,316 - $11,905	-179 Reduced 7.47%	2,218 $146,000
Q2 2018 Aug 09, 2018	BUY	$48.33 - $55.64 $31,269 - $35,999	647 Added 36.97%	2,397 $121,000
Q1 2018 May 16, 2018	BUY	$44.44 - $54.39 $74,481 - $91,157	1,676 Added 2264.86%	1,750 $92,000
Q4 2017 May 18, 2018	SELL	$37.77 - $47.75 $5,589 - $7,067	-148 Reduced 66.67%	74 $1,000
Q4 2017 Mar 07, 2018	BUY	$37.77 - $47.75 $8,384 - $10,600	222	222 $6,000

Others Institutions Holding EBS

# of Institutions

154

Shares Held

30.2M

Call Options Held

137K

Put Options Held

706K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $416M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Account

Private Capital Group, LLC Emergent Bio Solutions Inc. Transaction History